US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Keros Therapeutics, Inc.

14.35

-0.1000-0.69%

Volume:254.45K

Turnover:3.66M

Market Cap:582.07M

PE:-2.87

High:14.60

Open:14.40

Low:14.27

Close:14.45

Loading ...

Overview Company News Filings

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Traders Pull Back in Anticipation of More Inflation Data

MT Newswires Live

Top Premarket Decliners

MT Newswires Live

Keros Shares Dive on Halt to Trial of Pulmonary Hypertension Treatment

Keros Therapeutics Shares Drop After Voluntary Halt of Two Treatment Arms in TROPOS Trial

MT Newswires Live

BRIEF-Keros Therapeutics Announces Update On The Phase 2 Tropos Trial

BUZZ-Keros Therapeutics plunges as dosing halted in trial due to safety concerns

Keros Therapeutics Shares Fall 44.6% Premarket After Halting Dosing in Trial of Experimental Drug for Rare Type of Blood Disorder

THOMSON REUTERS

Keros Therapeutics voluntarily halts dosing of blood pressure treatment after safety review

Keros Therapeutics provides update on Phase 2 TROPOS trial

Keros Therapeutics Inc - Expects to Present Topline Data From All Treatment Arms in Trial Q2 2025

THOMSON REUTERS

Keros Therapeutics Inc - Halts Dosing in 3.0 Mg/Kg and 4.5 Mg/Kg Arms in Tropos Trial

THOMSON REUTERS

Keros Therapeutics Announces Update on the Phase 2 Tropos Trial

THOMSON REUTERS

Keros Therapeutics Inc - Dosing in 1.5 Mg/Kg Arm of Tropos Trial Remains Ongoing

THOMSON REUTERS

Wells Fargo Sticks to Its Buy Rating for Keros Therapeutics (KROS)

Positive Clinical Updates and Promising Therapeutic Potential for Elritercept in MDS and MF: A Strong Case for Continued Development

Keros Therapeutics presents clinical data from Elritercept program at ASH

Strategic Partnership with Takeda Boosts Keros Therapeutics’ Growth Prospects and Financial Stability

Strategic Advancements and Financial Gains Propel Keros Therapeutics’ Positive Outlook

Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst

BUZZ-Keros rises after blood cancer drug license deal with Takeda

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KROS/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KROS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KROS\",,,,,undefined,":{"symbol":"KROS","market":"US","secType":"STK","nameCN":"Keros Therapeutics, Inc.","latestPrice":14.35,"timestamp":1746036239397,"preClose":14.45,"halted":0,"volume":254454,"delay":0,"floatShares":30728772,"shares":40562047,"eps":-5.0044,"marketStatus":"Trading","change":-0.1,"latestTime":"04-30 14:04:09 EDT","open":14.4,"high":14.5968,"low":14.27,"amount":3657536.2998780003,"amplitude":0.022616,"askPrice":14.36,"askSize":349,"bidPrice":14.34,"bidSize":208,"shortable":3,"etf":0,"ttmEps":-5.0044,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":1586318400000,"exchange":"NASDAQ","adjPreClose":14.45,"preHourTrading":{"tag":"盘前","latestPrice":14.37,"preClose":14.45,"latestTime":"09:28 EDT","volume":1624,"amount":23008.555108,"timestamp":1746019680047},"postHourTrading":{"tag":"盘后","latestPrice":14.5,"preClose":14.45,"latestTime":"19:35 EDT","volume":734778,"amount":10617483.1,"timestamp":1745969723262},"volumeRatio":0.320089,"impliedVol":0.7571,"impliedVolPercentile":0.652},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KROS\",,,,,undefined,":{"symbol":"KROS","floatShares":30728772,"roa":"-26.73%","roe":"-41.46%","lyrEps":-5.0044,"volumeRatio":0.320089,"shares":40562047,"dividePrice":0,"high":14.5968,"amplitude":0.022616,"preClose":14.45,"low":14.27,"week52Low":9.12,"pbRate":"1.02","psRate":"163.96","week52High":72.37,"institutionHeld":0,"latestPrice":14.35,"committee":-0.253142,"eps":-5.0044,"divideRate":0,"volume":254454,"delay":0,"ttmEps":-5.0044,"open":14.4,"prevYearClose":15.83,"prevWeekClose":14.21,"prevMonthClose":10.19,"prevQuarterClose":10.19,"fiveDayClose":14.3,"twentyDayClose":9.55,"sixtyDayClose":11.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KROS\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490853963","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Traders Pull Back in Anticipation of More Inflation Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2490853963","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490853963?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:26","pubTimestamp":1734009963,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1% and the actively traded Invesco QQQ Trust (QQQ) retreated 0.3% in Thursday's premarket activity as traders pull back fr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FDN","RTH.AU","VHT.AU","PMR","IPK","PHX.AU","VIS","XLP","SLV","SOXX","SPY","IGV","SPY.AU","ADBE","KROS","NMR","UNG","XLE","VDC","IYJ","XLV","NDSN","EQR","BITO","VHT","RTH","USO","XLF",".DJI","EXI","GLD","QQQ","XLI","EEM","IYW","IGM","PHX",".IXIC","XLY","IYK","NMR.AU",".SPX","IBB","FAS","XSD","FAZ","XLK","IVV","TRNR"],"gpt_icon":1},{"id":"2490380071","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2490380071","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490380071?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:51","pubTimestamp":1734007896,"startTime":"0","endTime":"0","summary":"Keros Therapeutics (KROS) shares were down 72% pre-bell Thursday after the company said it voluntarily halted two treatment arms in a phase 2 study of cibotercept in combination with background therap","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INLX","BK4218","BK4181","BK4087","BK4097","MYGN","CLDT","KROS","SFHG","BK4139"],"gpt_icon":0},{"id":"2490800380","title":"Keros Shares Dive on Halt to Trial of Pulmonary Hypertension Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2490800380","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490800380?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:38","pubTimestamp":1734007080,"startTime":"0","endTime":"0","summary":"Keros Therapeutics' market value dived after the biopharmaceutical company said it halted dosing in a trial of a treatment for pulmonary arterial hypertension following unexpected, adverse pericardial-effusion events.Shares of the Lexington, Mass., company were down 71% at $19.69 in premarket trading, nearly wiping out a 73% gain from the start of the year.The company said the unanticipated events of pericardial effusion--when fluid builds up in the space around the heart--came in the Phase 2 clinical trial of 3 milligrams per kilogram and 4.6 mg/kg dosages of cibotercept, in combination with background therapy.Dosing in a 1.5 mg/kg arm of the trial will continue, the company said, adding it expected to present topline data from all arms of the trial in the second quarter of next year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490804576","title":"Keros Therapeutics Shares Drop After Voluntary Halt of Two Treatment Arms in TROPOS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490804576","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490804576?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:57","pubTimestamp":1734004629,"startTime":"0","endTime":"0","summary":"Keros Therapeutics  shares dropped 70% in recent premarket activity after the company said Thursday that it voluntarily halted dosing in the 3 mg/kg and 4.5 mg/kg treatment arms of its phase 2 TROPOS trial of cibotercept in combination with background therapy in patients with pulmonary arterial hypertension.The decision was based on a safety review due to the unanticipated observation of pericardial effusion adverse events in the trial, the company said.The company plans to work with investigators, the US Food and Drug Administration and other relevant regulatory authorities to address the findings as quickly as possible.Dosing in the 1.5 mg/kg treatment arm of the trial remains ongoing following the completion of a risk and benefit assessment.Keros expects to present topline data from all treatment arms in the trial in Q2 of 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","KROS"],"gpt_icon":0},{"id":"2490801105","title":"BRIEF-Keros Therapeutics Announces Update On The Phase 2 Tropos Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801105","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490801105?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:40","pubTimestamp":1734003639,"startTime":"0","endTime":"0","summary":"Dec 12  - Keros Therapeutics Inc   :   * KEROS THERAPEUTICS ANNOUNCES UPDATE ON THE PHASE 2 TROPOS TRIAL   * KEROS THERAPEUTICS INC - HALTS DOSING IN 3.0 MG/KG AND 4.5 MG/KG ARMS IN TROPOS TRIAL   * KEROS THERAPEUTICS INC - DOSING IN 1.5 MG/KG ARM OF TROPOS TRIAL REMAINS ONGOING   * KEROS THERAPEUTICS INC - EXPECTS TO PRESENT TOPLINE DATA FROM ALL TREATMENT ARMS IN TRIAL Q2 2025Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMPRXN33.USD","LU0348723411.USD","LENZ","IE00BMPRXQ63.HKD","BK4139","IE00BMPRXR70.SGD","KROS","BK4585","BK4141","BK4588"],"gpt_icon":1},{"id":"2490809088","title":"BUZZ-Keros Therapeutics plunges as dosing halted in trial due to safety concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2490809088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490809088?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:29","pubTimestamp":1734002971,"startTime":"0","endTime":"0","summary":"BUZZ-Keros Therapeutics plunges as dosing halted in trial due to safety concerns** Shares of drug developer Keros Therapeutics KROS.O fall ~71% to $20 premarket** KROS says it has halted dosing of 3.0 mg and 4.5 mg doses of its high blood pressure treatment in a mid-stage study due to fluid buildup around the heart** Dosing in the 1.5 mg/kg arm will continue after a risk-benefit review by an independent monitoring committee - KROS** Co has notified the U.S. FDA about it and expects to present data from all treatment arms in Q2 2025 - KROS** As of last close, stock has fallen 25.7% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4N3ND0RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490809874","title":"Keros Therapeutics Shares Fall 44.6% Premarket After Halting Dosing in Trial of Experimental Drug for Rare Type of Blood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2490809874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490809874?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:16","pubTimestamp":1734002210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4N3ND0R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KROS"],"gpt_icon":0},{"id":"2490809332","title":"Keros Therapeutics voluntarily halts dosing of blood pressure treatment after safety review","url":"https://stock-news.laohu8.com/highlight/detail?id=2490809332","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490809332?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:16","pubTimestamp":1734002196,"startTime":"0","endTime":"0","summary":"Keros Therapeutics voluntarily halts dosing of blood pressure treatment after safety review Dec 12  - Keros Therapeutics KROS.O said on Thursday that it has voluntarily halted dosing of its 3.0 milligram  and 4.5 mg doses of its high blood pressure treatment in a mid-stage study based on a safety review.   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4N3ND0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KROS"],"gpt_icon":0},{"id":"2490809963","title":"Keros Therapeutics provides update on Phase 2 TROPOS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490809963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490809963?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:05","pubTimestamp":1734001556,"startTime":"0","endTime":"0","summary":"Keros Therapeutics (KROS) has voluntarily halted dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial, a Phase 2 clinic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-provides-update-on-phase-2-tropos-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-provides-update-on-phase-2-tropos-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS","BK4139","LENZ"],"gpt_icon":0},{"id":"2490806139","title":"Keros Therapeutics Inc - Expects to Present Topline Data From All Treatment Arms in Trial Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490806139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490806139?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:00","pubTimestamp":1734001200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA6M3K4Y:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490806130","title":"Keros Therapeutics Inc - Halts Dosing in 3.0 Mg/Kg and 4.5 Mg/Kg Arms in Tropos Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490806130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490806130?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:00","pubTimestamp":1734001200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA6M3K4Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490580660","title":"Keros Therapeutics Announces Update on the Phase 2 Tropos Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490580660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490580660?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:00","pubTimestamp":1734001200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA6M3K4Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490061668","title":"Keros Therapeutics Inc - Dosing in 1.5 Mg/Kg Arm of Tropos Trial Remains Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2490061668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490061668?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:00","pubTimestamp":1734001200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA6M3K4Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KROS","BK4139"],"gpt_icon":0},{"id":"2490535958","title":"Wells Fargo Sticks to Its Buy Rating for Keros Therapeutics (KROS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490535958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490535958?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:56","pubTimestamp":1733918174,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Tiago Fauth maintained a Buy rating on Keros Therapeutics (KROS – Research Report) today and set a price target of $111.00. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-buy-rating-for-keros-therapeutics-kros?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-buy-rating-for-keros-therapeutics-kros?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS"],"gpt_icon":0},{"id":"2490894048","title":"Positive Clinical Updates and Promising Therapeutic Potential for Elritercept in MDS and MF: A Strong Case for Continued Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2490894048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490894048?lang=en_us&edition=fundamental","pubTime":"2024-12-11 00:05","pubTimestamp":1733846746,"startTime":"0","endTime":"0","summary":"Wedbush analyst Yun Zhong has maintained their bullish stance on KROS stock, giving a Buy rating yesterday. Yun Zhong’s rating is based on promisin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-clinical-updates-and-promising-therapeutic-potential-for-elritercept-in-mds-and-mf-a-strong-case-for-continued-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-clinical-updates-and-promising-therapeutic-potential-for-elritercept-in-mds-and-mf-a-strong-case-for-continued-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","MF","BK4113","BK4139","BK4563","KROS","BK4539"],"gpt_icon":0},{"id":"2490358700","title":"Keros Therapeutics presents clinical data from Elritercept program at ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2490358700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490358700?lang=en_us&edition=fundamental","pubTime":"2024-12-10 08:45","pubTimestamp":1733791509,"startTime":"0","endTime":"0","summary":"The company states: “Keros Therapeutics (KROS) announced that it presented additional data from its two ongoing Phase 2 clinical trials of elriterc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-presents-clinical-data-from-elritercept-program-at-ash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-presents-clinical-data-from-elritercept-program-at-ash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASH","KROS","LU2463526074.USD","BK4139","LENZ","BK4109"],"gpt_icon":0},{"id":"2489752604","title":"Strategic Partnership with Takeda Boosts Keros Therapeutics’ Growth Prospects and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2489752604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489752604?lang=en_us&edition=fundamental","pubTime":"2024-12-06 13:59","pubTimestamp":1733464780,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Thomas Smith has maintained their bullish stance on KROS stock, giving a Buy rating yesterday. Thomas Smith has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/strategic-partnership-with-takeda-boosts-keros-therapeutics-growth-prospects-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/strategic-partnership-with-takeda-boosts-keros-therapeutics-growth-prospects-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS","LENZ","BK4139"],"gpt_icon":0},{"id":"2489617344","title":"Strategic Advancements and Financial Gains Propel Keros Therapeutics’ Positive Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2489617344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489617344?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:10","pubTimestamp":1733415050,"startTime":"0","endTime":"0","summary":"Analyst Tiago Fauth of Wells Fargo maintained a Buy rating on Keros Therapeutics (KROS – Research Report), with a price target of $88.00. Tiago Fau...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/strategic-advancements-and-financial-gains-propel-keros-therapeutics-positive-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/strategic-advancements-and-financial-gains-propel-keros-therapeutics-positive-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3B42.SGD","LU0162691827.USD","LU0648001328.SGD","LU0256863811.USD","LU0971096721.USD","IE00B7SZLL34.SGD","LU2461242641.AUD","LENZ","LU1668664300.SGD","BK4504","LU0251142724.SGD","LU0787776722.HKD","LU0128525689.USD","LU0052756011.USD","BK4588","BK4207","LU1267930227.SGD","LU1074936037.SGD","BK4559","LU0149725797.USD","LU1363072403.SGD","LU1814569148.SGD","LU0477156953.USD","LU1280957306.USD","LU2361045086.USD","LU1069347547.HKD","LU0320765489.SGD","LU1201861249.SGD","LU0251131958.USD","LU0175139822.USD","LU0417517546.SGD","LU0070302665.USD","LU0640476718.USD","BK4139","LU0289960550.SGD","LU0742534661.SGD","BK4585","LU2361044865.SGD","LU0130102774.USD","LU0208291251.USD","LU1791807156.HKD","LU1035773651.USD","LU0048573561.USD","LU2236285917.USD","IE0002270589.USD","LU0683600562.USD","LU0072461881.USD","KROS","LU0130517989.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2488926283","title":"Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2488926283","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488926283?lang=en_us&edition=fundamental","pubTime":"2024-12-04 01:37","pubTimestamp":1733247444,"startTime":"0","endTime":"0","summary":"Elritercept is a late-stage investigational activin inhibitor designed to treat anemia associated with certain hematologic cancers, including myelodysplastic syndromes and myelofibrosis.Also Read: Analyst Sees Keros Therapeutics As Next Acceleron, the Set For Major Biotech Growth. The FDA has granted Fast Track designation for elritercept for very low-, low- and intermediate-risk MDS.Myelodysplastic syndromes and myelofibrosis are characterized by inadequate blood cell production, often leading to severe anemia.In early clinical studies, elritercept has shown promising clinical activity and a manageable safety profile in patients with very low-, low- and intermediate-risk myelodysplastic syndromes as a monotherapy and in patients with myelofibrosisin combination with standard of care.The Phase 3 RENEW trial evaluating elritercept in adult patients with transfusion-dependent anemia with very low-, low- or intermediate-risk myelodysplastic syndromeswill begin enrollment soon.Takeda will ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1nLH8gIx4cuqE1hjHF8nLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/5f5c05fa8aa1858c6c863baf52205a2d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1nLH8gIx4cuqE1hjHF8nLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/5f5c05fa8aa1858c6c863baf52205a2d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keros-therapeutics-licensing-deal-takeda-173724356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0106261372.USD","BK4504","TAK","LU0158827948.USD","LU1548497426.USD","LU2271345857.HKD","LU0971096721.USD","IE00BKVL7J92.USD","BK4585","LU1720051017.SGD","LU0098860793.USD","LU2028103732.USD","LU0225283273.USD","LU2089283258.USD","LU2357305700.SGD","LENZ","BK4516","BK4588","IE00BZ1G4Q59.USD","LU1363072403.SGD","KROS","LU2089284900.SGD","LU0106831901.USD","LU1720051108.HKD","LU0267386448.USD","BK4534","LU2023251221.USD","BK4139","LU1668664300.SGD","LU1074936037.SGD","LU0320765646.SGD","LU0314104364.USD","LU0158827781.USD","LU1989772840.SGD","BK4581","LU0006306889.USD","BK4007","LU1162221912.USD","LU1989772923.USD","BK4127","LU2111349929.HKD"],"gpt_icon":0},{"id":"2488194226","title":"BUZZ-Keros rises after blood cancer drug license deal with Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2488194226","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488194226?lang=en_us&edition=fundamental","pubTime":"2024-12-03 23:56","pubTimestamp":1733241403,"startTime":"0","endTime":"0","summary":"BUZZ-Keros rises after blood cancer drug license deal with Takeda ** Drug developer Keros Therapeutics' KROS.O shares rise 3.6% to $58.78** KROS says it entered into a global license agreement with Takeda 4502.T for experimental drug elritercept** Elritercept is being developed to treat low blood cell counts in patients with myelodysplastic syndrome and myelofibrosis, which are blood cancers ** KROS to receive $200 mln upfront and potentially over $1.1 bln in milestone payments from Takeda** Upfront payment will extend KROS' operational runway into Q4 2028, co says** Brokerage Truist Securities believes the partnership eases concerns about KROS’s ability to commercialize in different areas** Brokerage Guggenheim Securities says the partnership allows Keros to focus on the development of cibotercept for the treatment of pulmonary arterial hypertension** The agreement excludes commercialization in mainland China, Hong Kong, and Macau** All 15 brokerages rate the stock \"buy\" or higher; th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3N3N416Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":138,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KROS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"KROS","fiscalQuarterEnding":"2024/12","expectedEps":-0.93,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2024-11-06","symbol":"KROS","fiscalQuarterEnding":"2024/09","expectedEps":-1.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-1.41},{"market":"US","date":"2024-08-07","symbol":"KROS","fiscalQuarterEnding":"2024/06","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-1.25},{"market":"US","date":"2024-05-08","symbol":"KROS","fiscalQuarterEnding":"2024/03","expectedEps":-1.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-1.21},{"market":"US","date":"2024-02-28","symbol":"KROS","fiscalQuarterEnding":"2023/12","expectedEps":-1.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-1.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KROS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KROS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.3077,"hold":0.3846,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3077,"analysts":13,"updateTime":1737518400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KROS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KROS","date":"2025-04-29","current":-3.087299,"percent":0.943811,"low":-51.228143,"twenty":-27.210223,"median":-14.861838,"eighty":-10.192685,"high":-2.067581,"avg":-18.132881,"sd":11.106812,"marketCap":578414790},"quantilePoints":[{"date":"2020-05-01","current":-46.901302,"twenty":-48.259485,"median":-44.515524,"eighty":-33.089877,"marketCap":578574460},{"date":"2020-05-08","current":-44.59695,"twenty":-48.018465,"median":-44.767944,"eighty":-36.975055,"marketCap":550147972},{"date":"2020-05-15","current":-46.575598,"twenty":-48.018465,"median":-45.484492,"eighty":-42.351224,"marketCap":574556582},{"date":"2020-05-22","current":-26.146828,"twenty":-47.406143,"median":-45.028507,"eighty":-42.351224,"marketCap":550259986},{"date":"2020-05-29","current":-27.515922,"twenty":-47.044612,"median":-44.637663,"eighty":-29.747758,"marketCap":579072574},{"date":"2020-06-05","current":-30.474314,"twenty":-46.901302,"median":-44.458526,"eighty":-29.582009,"marketCap":641331943},{"date":"2020-06-12","current":-32.839113,"twenty":-46.852446,"median":-44.163927,"eighty":-30.560481,"marketCap":691099140},{"date":"2020-06-19","current":-36.879377,"twenty":-46.673309,"median":-43.603554,"eighty":-30.755792,"marketCap":776126498},{"date":"2020-06-26","current":-36.984692,"twenty":-46.556056,"median":-38.497398,"eighty":-31.080471,"marketCap":778342851},{"date":"2020-07-02","current":-34.275226,"twenty":-46.396462,"median":-37.338934,"eighty":-31.654916,"marketCap":721322135},{"date":"2020-07-10","current":-31.35513,"twenty":-46.062616,"median":-36.630451,"eighty":-31.615545,"marketCap":659868713},{"date":"2020-07-17","current":-28.789275,"twenty":-45.774368,"median":-35.912395,"eighty":-30.531758,"marketCap":605870296},{"date":"2020-07-24","current":-25.888327,"twenty":-45.507291,"median":-34.65819,"eighty":-29.068838,"marketCap":544819847},{"date":"2020-07-31","current":-30.732815,"twenty":-45.2337,"median":-34.275226,"eighty":-28.726086,"marketCap":646772082},{"date":"2020-08-07","current":-34.75393,"twenty":-44.924282,"median":-34.280013,"eighty":-28.930971,"marketCap":731396466},{"date":"2020-08-14","current":-26.88372,"twenty":-44.715832,"median":-34.2848,"eighty":-28.726086,"marketCap":778256824},{"date":"2020-08-21","current":-31.761534,"twenty":-44.621378,"median":-34.0263,"eighty":-28.557582,"marketCap":919464646},{"date":"2020-08-28","current":-36.973826,"twenty":-44.554608,"median":-34.275226,"eighty":-28.726086,"marketCap":1070355290},{"date":"2020-09-04","current":-34.186504,"twenty":-44.46504,"median":-34.2848,"eighty":-28.882761,"marketCap":989665106},{"date":"2020-09-11","current":-31.015925,"twenty":-44.393385,"median":-34.280013,"eighty":-29.047095,"marketCap":897880022},{"date":"2020-09-18","current":-31.48977,"twenty":-44.243269,"median":-34.045448,"eighty":-29.181812,"marketCap":911597353},{"date":"2020-09-25","current":-28.298286,"twenty":-44.144678,"median":-33.791613,"eighty":-28.836018,"marketCap":819207093},{"date":"2020-10-02","current":-25.615489,"twenty":-43.999284,"median":-33.60504,"eighty":-28.513579,"marketCap":741542790},{"date":"2020-10-09","current":-31.789407,"twenty":-43.676837,"median":-33.059318,"eighty":-28.301073,"marketCap":920271548},{"date":"2020-10-16","current":-36.0122,"twenty":-43.455097,"median":-33.145484,"eighty":-28.344444,"marketCap":1042517177},{"date":"2020-10-23","current":-37.566132,"twenty":-42.477393,"median":-33.579237,"eighty":-28.513579,"marketCap":1087501954},{"date":"2020-10-30","current":-38.743776,"twenty":-43.224396,"median":-33.786948,"eighty":-28.676452,"marketCap":1121593557},{"date":"2020-11-06","current":-38.701966,"twenty":-42.318516,"median":-34.0263,"eighty":-28.69602,"marketCap":1120383204},{"date":"2020-11-13","current":-35.854094,"twenty":-40.359028,"median":-34.007152,"eighty":-28.753261,"marketCap":1342233873},{"date":"2020-11-20","current":-43.268404,"twenty":-42.18852,"median":-34.127274,"eighty":-28.836018,"marketCap":1619795989},{"date":"2020-11-27","current":-47.055099,"twenty":-43.349825,"median":-34.280013,"eighty":-29.02299,"marketCap":1761554676},{"date":"2020-12-04","current":-47.878563,"twenty":-44.067682,"median":-34.399689,"eighty":-29.120925,"marketCap":1792381882},{"date":"2020-12-11","current":-47.56899,"twenty":-44.491096,"median":-34.457134,"eighty":-29.143516,"marketCap":1780792707},{"date":"2020-12-18","current":-50.126063,"twenty":-45.028507,"median":-34.619893,"eighty":-29.32585,"marketCap":1876519296},{"date":"2020-12-24","current":-48.621538,"twenty":-45.841676,"median":-34.907116,"eighty":-29.333168,"marketCap":1820195904},{"date":"2020-12-31","current":-43.674561,"twenty":-45.992954,"median":-35.280528,"eighty":-29.426909,"marketCap":1635000879},{"date":"2021-01-08","current":-43.916028,"twenty":-45.854162,"median":-35.720613,"eighty":-29.585356,"marketCap":1644040436},{"date":"2021-01-15","current":-44.324665,"twenty":-45.854162,"median":-36.0122,"eighty":-29.782743,"marketCap":1659338148},{"date":"2021-01-22","current":-41.575656,"twenty":-45.736909,"median":-36.09582,"eighty":-29.878806,"marketCap":1556426269},{"date":"2021-01-29","current":-35.322281,"twenty":-45.507291,"median":-36.357134,"eighty":-29.925236,"marketCap":1322324924},{"date":"2021-02-05","current":-40.541682,"twenty":-45.303838,"median":-36.381525,"eighty":-30.176314,"marketCap":1517718423},{"date":"2021-02-12","current":-37.204485,"twenty":-45.133714,"median":-36.684722,"eighty":-30.506748,"marketCap":1392787111},{"date":"2021-02-19","current":-41.259892,"twenty":-44.976394,"median":-36.832529,"eighty":-30.567905,"marketCap":1544605310},{"date":"2021-02-26","current":-40.535491,"twenty":-44.741888,"median":-36.973826,"eighty":-30.640903,"marketCap":1517486639},{"date":"2021-03-05","current":-36.294341,"twenty":-44.63574,"median":-36.905696,"eighty":-30.755793,"marketCap":1358714935},{"date":"2021-03-12","current":-40.343556,"twenty":-44.621827,"median":-36.973826,"eighty":-30.881348,"marketCap":1510301351},{"date":"2021-03-19","current":-36.721551,"twenty":-44.575779,"median":-36.979259,"eighty":-31.022492,"marketCap":1374707997},{"date":"2021-03-26","current":-28.933852,"twenty":-44.478068,"median":-36.879377,"eighty":-30.881348,"marketCap":1312468438},{"date":"2021-04-01","current":-30.144559,"twenty":-44.425955,"median":-36.721551,"eighty":-30.617925,"marketCap":1367387330},{"date":"2021-04-09","current":-30.862775,"twenty":-44.324665,"median":-36.535808,"eighty":-30.617925,"marketCap":1399966334},{"date":"2021-04-16","current":-29.072365,"twenty":-44.263104,"median":-36.332742,"eighty":-30.5554,"marketCap":1318751532},{"date":"2021-04-23","current":-31.598738,"twenty":-44.188453,"median":-36.071126,"eighty":-30.5554,"marketCap":1433350358},{"date":"2021-04-30","current":-30.182031,"twenty":-44.163927,"median":-35.987452,"eighty":-30.5554,"marketCap":1369087087},{"date":"2021-05-07","current":-25.069902,"twenty":-44.067682,"median":-35.76774,"eighty":-30.182031,"marketCap":1237299952},{"date":"2021-05-14","current":-23.068464,"twenty":-44.046656,"median":-35.625663,"eighty":-29.890295,"marketCap":1138520969},{"date":"2021-05-21","current":-23.507459,"twenty":-43.953177,"median":-35.519717,"eighty":-29.523815,"marketCap":1160187114},{"date":"2021-05-28","current":-25.754356,"twenty":-43.916028,"median":-35.347047,"eighty":-29.143516,"marketCap":1271080500},{"date":"2021-06-04","current":-22.223517,"twenty":-43.881356,"median":-35.280528,"eighty":-29.06249,"marketCap":1096819464},{"date":"2021-06-11","current":-24.177752,"twenty":-43.755092,"median":-34.869822,"eighty":-28.780272,"marketCap":1193268754},{"date":"2021-06-18","current":-25.386167,"twenty":-43.684787,"median":-34.619893,"eighty":-28.441109,"marketCap":1252908895},{"date":"2021-06-25","current":-21.189755,"twenty":-43.649795,"median":-34.457134,"eighty":-28.226319,"marketCap":1045799187},{"date":"2021-07-02","current":-19.34881,"twenty":-43.513853,"median":-34.399689,"eighty":-27.939937,"marketCap":954941160},{"date":"2021-07-09","current":-19.797245,"twenty":-43.452422,"median":-34.2848,"eighty":-27.712136,"marketCap":977073244},{"date":"2021-07-16","current":-18.872052,"twenty":-43.383133,"median":-34.197161,"eighty":-27.210559,"marketCap":931411261},{"date":"2021-07-23","current":-17.819409,"twenty":-43.300972,"median":-34.053032,"eighty":-26.757654,"marketCap":879459107},{"date":"2021-07-30","current":-17.370973,"twenty":-43.15547,"median":-33.98056,"eighty":-25.834739,"marketCap":857327024},{"date":"2021-08-06","current":-15.478513,"twenty":-43.020743,"median":-33.786948,"eighty":-25.538865,"marketCap":839229517},{"date":"2021-08-13","current":-14.88451,"twenty":-42.826054,"median":-33.587424,"eighty":-25.144432,"marketCap":807023267},{"date":"2021-08-20","current":-13.735244,"twenty":-42.647419,"median":-33.447864,"eighty":-24.96039,"marketCap":744711176},{"date":"2021-08-27","current":-15.052381,"twenty":-42.444937,"median":-33.059318,"eighty":-24.75647,"marketCap":816125034},{"date":"2021-09-03","current":-14.131246,"twenty":-42.317674,"median":-32.925241,"eighty":-24.237228,"marketCap":766182009},{"date":"2021-09-10","current":-13.55446,"twenty":-42.235947,"median":-32.846057,"eighty":-23.885089,"marketCap":734909274},{"date":"2021-09-17","current":-13.227328,"twenty":-42.02268,"median":-32.752161,"eighty":-23.556551,"marketCap":717172499},{"date":"2021-09-24","current":-14.20442,"twenty":-41.805047,"median":-32.500174,"eighty":-23.089234,"marketCap":770149446},{"date":"2021-10-01","current":-17.178739,"twenty":-41.686944,"median":-32.280502,"eighty":-22.404779,"marketCap":931414072},{"date":"2021-10-08","current":-15.904646,"twenty":-41.594231,"median":-32.196605,"eighty":-21.965841,"marketCap":862334000},{"date":"2021-10-15","current":-16.782737,"twenty":-41.507672,"median":-31.998828,"eighty":-20.622367,"marketCap":909943239},{"date":"2021-10-22","current":-16.709563,"twenty":-41.347374,"median":-31.789407,"eighty":-19.797245,"marketCap":905975802},{"date":"2021-10-29","current":-17.95783,"twenty":-41.245032,"median":-31.5873,"eighty":-19.275172,"marketCap":973655602},{"date":"2021-11-05","current":-20.863303,"twenty":-41.220267,"median":-31.48977,"eighty":-19.017439,"marketCap":1303539181},{"date":"2021-11-12","current":-23.170213,"twenty":-41.08777,"median":-31.384124,"eighty":-19.108071,"marketCap":1447674908},{"date":"2021-11-19","current":-22.409981,"twenty":-40.817505,"median":-31.298835,"eighty":-19.275172,"marketCap":1400175634},{"date":"2021-11-26","current":-21.009358,"twenty":-40.69167,"median":-31.115778,"eighty":-19.337481,"marketCap":1312664657},{"date":"2021-12-03","current":-20.282831,"twenty":-40.629035,"median":-31.000912,"eighty":-19.370524,"marketCap":1267271263},{"date":"2021-12-10","current":-20.155501,"twenty":-40.540444,"median":-30.847704,"eighty":-19.525351,"marketCap":1259315719},{"date":"2021-12-17","current":-19.159336,"twenty":-40.497104,"median":-30.586662,"eighty":-19.255347,"marketCap":1197075292},{"date":"2021-12-23","current":-22.031738,"twenty":-40.343556,"median":-30.427429,"eighty":-19.334649,"marketCap":1376542991},{"date":"2021-12-31","current":-21.911899,"twenty":-40.219726,"median":-30.182031,"eighty":-19.34881,"marketCap":1369055421},{"date":"2022-01-07","current":-19.773513,"twenty":-40.058749,"median":-30.043148,"eighty":-19.457378,"marketCap":1235449089},{"date":"2022-01-14","current":-19.391525,"twenty":-39.804899,"median":-29.871147,"eighty":-19.384035,"marketCap":1211582459},{"date":"2022-01-21","current":-17.339274,"twenty":-39.735554,"median":-29.617401,"eighty":-19.220284,"marketCap":1083357819},{"date":"2022-01-28","current":-15.773871,"twenty":-39.67364,"median":-29.41159,"eighty":-18.974012,"marketCap":985551432},{"date":"2022-02-04","current":-17.844846,"twenty":-39.632776,"median":-29.143516,"eighty":-18.700658,"marketCap":1114946006},{"date":"2022-02-11","current":-19.28292,"twenty":-39.491611,"median":-29.0908,"eighty":-18.755802,"marketCap":1204796848},{"date":"2022-02-18","current":-19.507619,"twenty":-39.250144,"median":-28.933852,"eighty":-18.805161,"marketCap":1218836043},{"date":"2022-02-25","current":-19.957017,"twenty":-39.138698,"median":-28.789275,"eighty":-18.795922,"marketCap":1246914431},{"date":"2022-03-04","current":-18.387869,"twenty":-39.032228,"median":-28.679268,"eighty":-18.7434,"marketCap":1148874058},{"date":"2022-03-11","current":-21.142984,"twenty":-38.841332,"median":-28.312223,"eighty":-18.754877,"marketCap":1242023442},{"date":"2022-03-18","current":-22.376835,"twenty":-38.71869,"median":-28.253126,"eighty":-18.762873,"marketCap":1314504810},{"date":"2022-03-25","current":-20.87742,"twenty":-38.682625,"median":-28.11711,"eighty":-18.795922,"marketCap":1226423148},{"date":"2022-04-01","current":-24.288896,"twenty":-38.667294,"median":-27.933777,"eighty":-18.848991,"marketCap":1426826930},{"date":"2022-04-08","current":-26.576833,"twenty":-38.564707,"median":-27.740822,"eighty":-18.948522,"marketCap":1561229467},{"date":"2022-04-14","current":-26.405238,"twenty":-38.45326,"median":-27.515922,"eighty":-19.005166,"marketCap":1551149277},{"date":"2022-04-22","current":-24.12158,"twenty":-38.340205,"median":-27.300549,"eighty":-19.017439,"marketCap":1416998103},{"date":"2022-04-29","current":-21.672626,"twenty":-38.242483,"median":-27.107961,"eighty":-19.077597,"marketCap":1273136770},{"date":"2022-05-06","current":-17.062305,"twenty":-38.103329,"median":-26.853446,"eighty":-19.017439,"marketCap":1143942207},{"date":"2022-05-13","current":-15.76995,"twenty":-37.905998,"median":-26.682976,"eighty":-18.786682,"marketCap":1057296306},{"date":"2022-05-20","current":-13.217505,"twenty":-37.783262,"median":-26.306517,"eighty":-18.689587,"marketCap":886167647},{"date":"2022-05-27","current":-12.600904,"twenty":-37.677682,"median":-25.888327,"eighty":-18.525957,"marketCap":844827578},{"date":"2022-06-03","current":-12.396565,"twenty":-37.61363,"median":-25.849596,"eighty":-18.372889,"marketCap":831127671},{"date":"2022-06-10","current":-10.421288,"twenty":-37.552002,"median":-25.704792,"eighty":-18.114715,"marketCap":698695240},{"date":"2022-06-17","current":-9.85129,"twenty":-37.494246,"median":-25.620253,"eighty":-17.967027,"marketCap":660479711},{"date":"2022-06-24","current":-10.238458,"twenty":-37.489292,"median":-25.548433,"eighty":-17.893265,"marketCap":686437429},{"date":"2022-07-01","current":-10.069968,"twenty":-37.338934,"median":-25.405048,"eighty":-17.786366,"marketCap":675141015},{"date":"2022-07-08","current":-10.403363,"twenty":-37.32558,"median":-25.278079,"eighty":-17.683933,"marketCap":697493494},{"date":"2022-07-15","current":-10.959022,"twenty":-37.311092,"median":-25.085898,"eighty":-17.500423,"marketCap":734747626},{"date":"2022-07-22","current":-10.238458,"twenty":-37.246983,"median":-24.992016,"eighty":-17.360246,"marketCap":686437429},{"date":"2022-07-29","current":-11.500341,"twenty":-37.209919,"median":-24.819722,"eighty":-17.171852,"marketCap":771040361},{"date":"2022-08-05","current":-12.225625,"twenty":-37.078491,"median":-24.746557,"eighty":-17.055461,"marketCap":962022231},{"date":"2022-08-12","current":-12.906463,"twenty":-37.004579,"median":-24.300481,"eighty":-16.768102,"marketCap":1015596696},{"date":"2022-08-19","current":-11.872113,"twenty":-36.986549,"median":-24.266688,"eighty":-16.529947,"marketCap":934204721},{"date":"2022-08-26","current":-11.898299,"twenty":-36.975999,"median":-24.12158,"eighty":-16.41734,"marketCap":936265277},{"date":"2022-09-02","current":-11.790282,"twenty":-36.940378,"median":-23.951133,"eighty":-16.227869,"marketCap":927765483},{"date":"2022-09-09","current":-12.755893,"twenty":-36.900433,"median":-23.875648,"eighty":-15.930472,"marketCap":1003748497},{"date":"2022-09-16","current":-12.032503,"twenty":-36.82316,"median":-23.630188,"eighty":-15.772303,"marketCap":946825629},{"date":"2022-09-23","current":-11.469502,"twenty":-36.747203,"median":-23.441374,"eighty":-15.054963,"marketCap":902523668},{"date":"2022-09-30","current":-12.314003,"twenty":-36.71822,"median":-23.170213,"eighty":-14.948215,"marketCap":968976609},{"date":"2022-10-07","current":-13.050487,"twenty":-36.678467,"median":-23.072526,"eighty":-14.788509,"marketCap":1026929755},{"date":"2022-10-14","current":-14.37943,"twenty":-36.51228,"median":-22.912692,"eighty":-14.518639,"marketCap":1131502989},{"date":"2022-10-21","current":-14.716576,"twenty":-36.396183,"median":-22.697395,"eighty":-14.487648,"marketCap":1158032651},{"date":"2022-10-28","current":-16.631433,"twenty":-36.352255,"median":-22.507574,"eighty":-14.487648,"marketCap":1308710832},{"date":"2022-11-04","current":-16.357599,"twenty":-36.309701,"median":-22.359704,"eighty":-14.518639,"marketCap":1339703728},{"date":"2022-11-11","current":-15.496673,"twenty":-36.175228,"median":-22.249091,"eighty":-14.518639,"marketCap":1269193006},{"date":"2022-11-18","current":-15.567296,"twenty":-36.066187,"median":-22.232031,"eighty":-14.610752,"marketCap":1274977088},{"date":"2022-11-25","current":-16.38114,"twenty":-36.032739,"median":-22.224592,"eighty":-14.68304,"marketCap":1341631756},{"date":"2022-12-02","current":-17.215162,"twenty":-36.002301,"median":-22.215242,"eighty":-14.725741,"marketCap":1409939018},{"date":"2022-12-09","current":-16.717439,"twenty":-35.957429,"median":-22.11745,"eighty":-14.741038,"marketCap":1369175007},{"date":"2022-12-16","current":-16.495482,"twenty":-35.889075,"median":-22.054073,"eighty":-14.78371,"marketCap":1350996461},{"date":"2022-12-23","current":-15.701815,"twenty":-35.785011,"median":-22.018392,"eighty":-14.849621,"marketCap":1285994389},{"date":"2022-12-30","current":-16.149094,"twenty":-35.67148,"median":-21.977435,"eighty":-14.860909,"marketCap":1322626913},{"date":"2023-01-06","current":-16.034752,"twenty":-35.631854,"median":-21.93532,"eighty":-14.873727,"marketCap":1313262207},{"date":"2023-01-13","current":-16.532475,"twenty":-35.625663,"median":-21.923334,"eighty":-14.88451,"marketCap":1354026219},{"date":"2023-01-20","current":-16.999931,"twenty":-35.595944,"median":-21.864769,"eighty":-14.89484,"marketCap":1392311338},{"date":"2023-01-27","current":-19.512087,"twenty":-35.587409,"median":-21.704011,"eighty":-14.921528,"marketCap":1598059423},{"date":"2023-02-03","current":-19.31367,"twenty":-35.479268,"median":-21.453489,"eighty":-14.944692,"marketCap":1581808904},{"date":"2023-02-10","current":-18.002103,"twenty":-35.392928,"median":-21.206288,"eighty":-14.959387,"marketCap":1474390226},{"date":"2023-02-17","current":-18.4931,"twenty":-35.353254,"median":-21.099237,"eighty":-14.964654,"marketCap":1514603372},{"date":"2023-02-24","current":-17.891124,"twenty":-35.332187,"median":-21.061787,"eighty":-14.967338,"marketCap":1465300953},{"date":"2023-03-03","current":-16.170655,"twenty":-35.297229,"median":-20.977525,"eighty":-14.998103,"marketCap":1692727995},{"date":"2023-03-10","current":-12.068019,"twenty":-35.234558,"median":-20.889518,"eighty":-14.940408,"marketCap":1263268178},{"date":"2023-03-17","current":-11.607325,"twenty":-35.025834,"median":-20.819291,"eighty":-14.867318,"marketCap":1215043122},{"date":"2023-03-24","current":-11.29656,"twenty":-34.862363,"median":-20.755481,"eighty":-14.730324,"marketCap":1182512611},{"date":"2023-03-31","current":-11.640037,"twenty":-34.785369,"median":-20.623624,"eighty":-14.518639,"marketCap":1218467387},{"date":"2023-04-06","current":-10.846769,"twenty":-34.700315,"median":-20.531812,"eighty":-14.402421,"marketCap":1135428977},{"date":"2023-04-14","current":-10.811331,"twenty":-34.571967,"median":-20.44761,"eighty":-14.32313,"marketCap":1131719357},{"date":"2023-04-21","current":-12.299729,"twenty":-34.49056,"median":-20.314664,"eighty":-14.227461,"marketCap":1287523384},{"date":"2023-04-28","current":-12.369584,"twenty":-34.468623,"median":-20.282831,"eighty":-14.147602,"marketCap":1294835690},{"date":"2023-05-04","current":-12.784538,"twenty":-34.445645,"median":-20.207931,"eighty":-13.911339,"marketCap":1338272670},{"date":"2023-05-12","current":-11.401521,"twenty":-34.415008,"median":-20.097454,"eighty":-13.800575,"marketCap":1325962633},{"date":"2023-05-19","current":-11.884851,"twenty":-34.401604,"median":-20.046897,"eighty":-13.720609,"marketCap":1382172562},{"date":"2023-05-26","current":-12.782829,"twenty":-34.307778,"median":-19.917694,"eighty":-13.381425,"marketCap":1486604693},{"date":"2023-06-02","current":-12.159587,"twenty":-34.2848,"median":-19.869011,"eighty":-13.270753,"marketCap":1414123469},{"date":"2023-06-09","current":-12.454673,"twenty":-34.279056,"median":-19.797245,"eighty":-13.200414,"marketCap":1448441110},{"date":"2023-06-16","current":-9.877756,"twenty":-34.234781,"median":-19.759611,"eighty":-13.083874,"marketCap":1148753437},{"date":"2023-06-23","current":-10.556963,"twenty":-34.199292,"median":-19.692006,"eighty":-13.041976,"marketCap":1227743179},{"date":"2023-06-30","current":-10.142316,"twenty":-34.162812,"median":-19.636153,"eighty":-13.000016,"marketCap":1179520977},{"date":"2023-07-07","current":-9.915914,"twenty":-34.068043,"median":-19.539813,"eighty":-12.952223,"marketCap":1153191063},{"date":"2023-07-14","current":-10.246614,"twenty":-34.053032,"median":-19.496384,"eighty":-12.896644,"marketCap":1191650488},{"date":"2023-07-21","current":-10.8724,"twenty":-34.045448,"median":-19.464551,"eighty":-12.782829,"marketCap":1264427554},{"date":"2023-07-28","current":-9.987142,"twenty":-34.007152,"median":-19.44819,"eighty":-12.59889,"marketCap":1161474631},{"date":"2023-08-04","current":-10.241526,"twenty":-33.953969,"median":-19.410249,"eighty":-12.520605,"marketCap":1191058804},{"date":"2023-08-10","current":-8.52369,"twenty":-33.827817,"median":-19.3728,"eighty":-12.452638,"marketCap":1078553661},{"date":"2023-08-18","current":-7.864956,"twenty":-33.788814,"median":-19.334649,"eighty":-12.398599,"marketCap":995200091},{"date":"2023-08-25","current":-8.333806,"twenty":-33.655046,"median":-19.279175,"eighty":-12.372546,"marketCap":1054526475},{"date":"2023-09-01","current":-8.230659,"twenty":-33.608446,"median":-19.23049,"eighty":-12.333116,"marketCap":1041474671},{"date":"2023-09-08","current":-8.380691,"twenty":-33.583901,"median":-19.101802,"eighty":-12.29041,"marketCap":1060459114},{"date":"2023-09-15","current":-8.240036,"twenty":-33.559984,"median":-19.018383,"eighty":-12.205315,"marketCap":1042661198},{"date":"2023-09-22","current":-7.738367,"twenty":-33.490092,"median":-18.903385,"eighty":-12.159931,"marketCap":979181967},{"date":"2023-09-29","current":-7.651629,"twenty":-33.439477,"median":-18.818537,"eighty":-12.098918,"marketCap":968206586},{"date":"2023-10-06","current":-7.698514,"twenty":-33.260845,"median":-18.754877,"eighty":-12.02163,"marketCap":974139225},{"date":"2023-10-13","current":-6.627193,"twenty":-33.042084,"median":-18.72744,"eighty":-11.988641,"marketCap":838578437},{"date":"2023-10-20","current":-6.549832,"twenty":-32.950173,"median":-18.673796,"eighty":-11.924572,"marketCap":828789584},{"date":"2023-10-27","current":-6.60375,"twenty":-32.934854,"median":-18.664998,"eighty":-11.888103,"marketCap":835612118},{"date":"2023-11-03","current":-6.720963,"twenty":-32.925241,"median":-18.545226,"eighty":-11.869021,"marketCap":850443714},{"date":"2023-11-10","current":-6.197245,"twenty":-32.85839,"median":-18.431311,"eighty":-11.800102,"marketCap":882902869},{"date":"2023-11-17","current":-6.619928,"twenty":-32.846057,"median":-18.378507,"eighty":-11.752571,"marketCap":943121219},{"date":"2023-11-24","current":-6.470622,"twenty":-32.840502,"median":-18.277994,"eighty":-11.66594,"marketCap":921850061},{"date":"2023-12-01","current":-6.380197,"twenty":-32.787179,"median":-18.180341,"eighty":-11.613511,"marketCap":908967528},{"date":"2023-12-08","current":-7.467396,"twenty":-32.738941,"median":-18.163527,"eighty":-11.574901,"marketCap":1063857512},{"date":"2023-12-15","current":-7.097286,"twenty":-32.590596,"median":-18.08827,"eighty":-11.497204,"marketCap":1011129007},{"date":"2023-12-22","current":-7.641937,"twenty":-32.511282,"median":-18.005865,"eighty":-11.450125,"marketCap":1088723796},{"date":"2023-12-29","current":-8.632402,"twenty":-32.439367,"median":-17.972176,"eighty":-11.43457,"marketCap":1229832466},{"date":"2024-01-05","current":-11.479812,"twenty":-32.348156,"median":-17.961785,"eighty":-11.401521,"marketCap":1635494396},{"date":"2024-01-12","current":-12.261064,"twenty":-32.283816,"median":-17.941569,"eighty":-11.401521,"marketCap":1746797029},{"date":"2024-01-19","current":-12.370794,"twenty":-32.278514,"median":-17.894487,"eighty":-11.426592,"marketCap":1762429843},{"date":"2024-01-26","current":-13.427535,"twenty":-32.274831,"median":-17.89067,"eighty":-11.436279,"marketCap":1912980637},{"date":"2024-02-02","current":-13.649379,"twenty":-32.212132,"median":-17.83059,"eighty":-11.440257,"marketCap":1944586109},{"date":"2024-02-09","current":-12.23721,"twenty":-32.183027,"median":-17.750069,"eighty":-11.450125,"marketCap":1743398591},{"date":"2024-02-16","current":-14.042974,"twenty":-32.040861,"median":-17.687557,"eighty":-11.466081,"marketCap":2000660332},{"date":"2024-02-23","current":-14.548683,"twenty":-31.99736,"median":-17.611712,"eighty":-11.475688,"marketCap":2072707214},{"date":"2024-03-01","current":-15.875519,"twenty":-31.941316,"median":-17.470242,"eighty":-11.481482,"marketCap":2428827390},{"date":"2024-03-08","current":-16.397647,"twenty":-31.836791,"median":-17.370973,"eighty":-11.48383,"marketCap":2508708824},{"date":"2024-03-15","current":-15.247554,"twenty":-31.772683,"median":-17.352381,"eighty":-11.494066,"marketCap":2332753773},{"date":"2024-03-22","current":-16.233012,"twenty":-31.663856,"median":-17.26897,"eighty":-11.508945,"marketCap":2483520984},{"date":"2024-03-28","current":-15.207571,"twenty":-31.589587,"median":-17.215162,"eighty":-11.523388,"marketCap":2326636726},{"date":"2024-04-05","current":-14.513752,"twenty":-31.559445,"median":-17.142152,"eighty":-11.54764,"marketCap":2220487973},{"date":"2024-04-12","current":-14.558439,"twenty":-31.5168,"median":-17.062305,"eighty":-11.569664,"marketCap":2227324673},{"date":"2024-04-19","current":-13.897432,"twenty":-31.469708,"median":-17.006078,"eighty":-11.578829,"marketCap":2126195984},{"date":"2024-04-26","current":-12.775265,"twenty":-31.429017,"median":-16.949486,"eighty":-11.584461,"marketCap":1954513323},{"date":"2024-05-03","current":-13.461296,"twenty":-31.389923,"median":-16.870455,"eighty":-11.596908,"marketCap":2059470580},{"date":"2024-05-10","current":-12.965726,"twenty":-31.35324,"median":-16.784699,"eighty":-11.610418,"marketCap":2078431833},{"date":"2024-05-17","current":-12.153117,"twenty":-31.329776,"median":-16.764521,"eighty":-11.618373,"marketCap":1948169005},{"date":"2024-05-24","current":-11.065887,"twenty":-31.273561,"median":-16.709563,"eighty":-11.596908,"marketCap":1773883835},{"date":"2024-05-31","current":-10.424354,"twenty":-31.211675,"median":-16.697947,"eighty":-11.567046,"marketCap":1671044760},{"date":"2024-06-07","current":-10.96009,"twenty":-31.102374,"median":-16.642519,"eighty":-11.501239,"marketCap":1756924409},{"date":"2024-06-14","current":-11.142421,"twenty":-31.048759,"median":-16.607715,"eighty":-11.479812,"marketCap":1786152357},{"date":"2024-06-21","current":-10.221764,"twenty":-31.022492,"median":-16.558548,"eighty":-11.440257,"marketCap":1638569263},{"date":"2024-06-28","current":-10.145231,"twenty":-31.00992,"median":-16.539952,"eighty":-11.433715,"marketCap":1626300742},{"date":"2024-07-05","current":-9.492442,"twenty":-30.985898,"median":-16.535838,"eighty":-11.381066,"marketCap":1521657472},{"date":"2024-07-12","current":-10.34782,"twenty":-30.862775,"median":-16.498845,"eighty":-11.329272,"marketCap":1658776239},{"date":"2024-07-15","current":-10.678716,"twenty":-30.859761,"median":-16.497163,"eighty":-11.320063,"marketCap":1711819551},{"date":"2024-08-02","current":-11.336006,"twenty":-30.856747,"median":-16.495482,"eighty":-11.322365,"marketCap":1817184498},{"date":"2024-08-09","current":-9.915601,"twenty":-30.801748,"median":-16.470902,"eighty":-11.188346,"marketCap":1666356327},{"date":"2024-08-16","current":-10.279537,"twenty":-30.686859,"median":-16.417458,"eighty":-11.1319,"marketCap":1727517345},{"date":"2024-08-23","current":-9.989281,"twenty":-30.592915,"median":-16.398647,"eighty":-11.064536,"marketCap":1678738619},{"date":"2024-08-30","current":-10.116547,"twenty":-30.522966,"median":-16.391229,"eighty":-11.009162,"marketCap":1700126215},{"date":"2024-09-06","current":-11.985351,"twenty":-30.45556,"median":-16.364325,"eighty":-10.989832,"marketCap":2014186166},{"date":"2024-09-13","current":-12.592656,"twenty":-30.348737,"median":-16.317622,"eighty":-11.003759,"marketCap":2116246270},{"date":"2024-09-20","current":-12.798068,"twenty":-30.213615,"median":-16.243257,"eighty":-11.025369,"marketCap":2150766600},{"date":"2024-09-27","current":-12.699828,"twenty":-30.174537,"median":-16.231836,"eighty":-11.031458,"marketCap":2134256877},{"date":"2024-10-04","current":-13.374116,"twenty":-30.137377,"median":-16.193029,"eighty":-11.057378,"marketCap":2247573610},{"date":"2024-10-11","current":-12.903007,"twenty":-30.082448,"median":-16.147413,"eighty":-11.064086,"marketCap":2168401985},{"date":"2024-10-18","current":-13.639812,"twenty":-29.960177,"median":-16.081834,"eighty":-11.074891,"marketCap":2292224905},{"date":"2024-10-25","current":-13.298202,"twenty":-29.886465,"median":-16.027808,"eighty":-11.114228,"marketCap":2234816097},{"date":"2024-10-31","current":-13.316064,"twenty":-29.871147,"median":-15.977742,"eighty":-11.127512,"marketCap":2237817865},{"date":"2024-11-08","current":-14.98531,"twenty":-29.650138,"median":-15.913684,"eighty":-11.131166,"marketCap":2720882662},{"date":"2024-11-15","current":-13.4638,"twenty":-29.617401,"median":-15.895962,"eighty":-11.133,"marketCap":2444622133},{"date":"2024-11-22","current":-12.01145,"twenty":-29.523815,"median":-15.852515,"eighty":-11.142421,"marketCap":2180918900},{"date":"2024-11-29","current":-12.881521,"twenty":-29.495309,"median":-15.798629,"eighty":-11.147823,"marketCap":2338897795},{"date":"2024-12-06","current":-14.414186,"twenty":-29.365635,"median":-15.771911,"eighty":-11.161789,"marketCap":2617183695},{"date":"2024-12-13","current":-4.111646,"twenty":-29.32768,"median":-15.732051,"eighty":-11.161789,"marketCap":746551547},{"date":"2024-12-20","current":-3.774772,"twenty":-29.179983,"median":-15.711054,"eighty":-11.130435,"marketCap":685385360},{"date":"2024-12-27","current":-3.750232,"twenty":-29.129961,"median":-15.696866,"eighty":-11.064987,"marketCap":680929545},{"date":"2025-01-03","current":-3.551677,"twenty":-29.116249,"median":-15.609064,"eighty":-11.025369,"marketCap":644877951},{"date":"2025-01-10","current":-3.321889,"twenty":-29.10186,"median":-15.600926,"eighty":-10.978218,"marketCap":603155320},{"date":"2025-01-17","current":-2.346962,"twenty":-29.06249,"median":-15.587474,"eighty":-10.96009,"marketCap":426137942},{"date":"2025-01-24","current":-2.681605,"twenty":-29.02299,"median":-15.569768,"eighty":-10.943628,"marketCap":486899056},{"date":"2025-01-31","current":-2.612446,"twenty":-28.933852,"median":-15.528609,"eighty":-10.930909,"marketCap":474341759},{"date":"2025-02-07","current":-2.568942,"twenty":-28.88255,"median":-15.492155,"eighty":-10.846769,"marketCap":466442814},{"date":"2025-02-14","current":-2.264417,"twenty":-28.789275,"median":-15.421005,"eighty":-10.718834,"marketCap":411150201},{"date":"2025-02-21","current":-2.460741,"twenty":-28.753261,"median":-15.317173,"eighty":-10.678278,"marketCap":446796721},{"date":"2025-02-28","current":-2.383672,"twenty":-28.69602,"median":-15.247554,"eighty":-10.648293,"marketCap":446588137},{"date":"2025-03-07","current":-2.582853,"twenty":-28.676452,"median":-15.188803,"eighty":-10.569793,"marketCap":483905220},{"date":"2025-03-14","current":-2.483262,"twenty":-28.513579,"median":-15.150285,"eighty":-10.547528,"marketCap":465246679},{"date":"2025-03-21","current":-2.476767,"twenty":-28.344444,"median":-15.111505,"eighty":-10.465835,"marketCap":464029817},{"date":"2025-03-28","current":-2.379342,"twenty":-28.301073,"median":-15.056685,"eighty":-10.417703,"marketCap":445776896},{"date":"2025-04-04","current":-2.225627,"twenty":-28.276934,"median":-15.052381,"eighty":-10.357307,"marketCap":416977843},{"date":"2025-04-11","current":-2.649968,"twenty":-28.174619,"median":-15.012687,"eighty":-10.277023,"marketCap":496479455},{"date":"2025-04-17","current":-2.929254,"twenty":-27.927617,"median":-14.967002,"eighty":-10.243764,"marketCap":548804495},{"date":"2025-04-25","current":-3.121939,"twenty":-27.410394,"median":-14.88451,"eighty":-10.219838,"marketCap":584904717},{"date":"2025-04-29","current":-3.087299,"twenty":-27.210223,"median":-14.861838,"eighty":-10.192685,"marketCap":578414790}],"updateTime":1746018978349}}}